Applications

1. Breast cancer:

- Docetaxel trihydrate in combination with doxorubicin and cyclophosphamide is indicated for the adjuvant treatment of patients with:

operable node-positive breast cancer;

operable node-negative breast cancer.

-Docetaxel trihydrate in combination with doxorubicin is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have not previously received cytotoxic therapy for this condition.

- Docetaxel trihydrate monotherapy is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of cytotoxic therapy.

Technical specification

EP, USP

Packaging

Packaging is confirmed with the quotation.

On a small screen, scroll the technical table horizontally.

Published reference specifications. Confirm the current grade, SDS / TDS / COA, packaging and delivery terms with your quotation.